Related Experiment Video
Updated: Jul 28, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
Ali Riza Caliskan1, Muhsin Murat Muhip Harputluoglu2, Emine Samdanci3
1Department of Gastroenterology, Adiyaman Training and Research Hospital, Adiyaman, Turkiye.
Abstract:
Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.

